I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

LONDON -- British pop star Cliff Richard said Monday he has been given the all-clear after treatment for prostate cancer. The ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at ...

Cliff Richard, 85, said in an interview with “Good Morning Britain” that he was diagnosed with prostate cancer in 2024 after ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has signed an agreement with ...

Legendary British singer Cliff Richard, 85, shares his prostate cancer journey and advocates for a national screening program ...

EDX Medical is launching a bowel cancer testing service in the UK in the coming weeks that is intended to improve the ...